Testing effectiveness (Phase 2)Looking for participantsNCT06769633
What this trial is testing
Pharmacokinetics and Safety of Givinostat in DMD Patients Ages From at Least 2 Years to Less Then 6 Years Old
Who this might be right for
Duchenne Muscular Dystrophy
Italfarmaco 18